PPP
- 6
- Portfolio companies on reccy
- 0
- Hiring now
- 0
- Open roles in the portfolio
- Feb 2021
- Latest portfolio round
Hiring now in the portfolio0
Apply on each company's siteNone of their companies on reccy has an open role right now. Browse all neurotech roles
Portfolio on reccy6
From company funding records- Debt · $272K · Feb 2021None
MedRhythms
Portland, ME · Led a round · Debt · $272K · Feb 2021
- Debt · $893K · Jan 2021None
BIOPAC Systems
Goleta, California, United States · Led a round · Debt · $893K · Jan 2021
- Debt · $132K · Jan 2021None
NeuroSigma
Los Angeles, CA · Led a round · Debt · $132K · Jan 2021
- Debt · $22KNone
Nexalin Technology
Houston, Texas · Led a round · Debt · $22K
- Debt · $44KNone
Symbios
Vitória, Espírito Santo, Brazil · Led a round · Debt · $44K
- Debt · $150K · Jan 2020None
NeuroSky
San Jose, CA · Led a round · Debt · $150K · Jan 2020
Their companies, round by round
From company funding records- MedRhythmsPortland, ME
Digital therapeutics · Neurorehabilitation and assistive tech · Wearables
- Jul 2026Series B · $7.2M
- Mar 2026Venture Round · $3.3M
- Mar 2025Series B · $2M
- Dec 2023Venture Round · $19.8M
- Nov 2023Series B · $8.9M
- Nov 2021Series B · $2M
- BIOPAC SystemsGoleta, California, United States
Wearables
- Jan 2021Debt · $893KLed
- Apr 2020Debt · $350KLed
- NeuroSigmaLos Angeles, CA
Neuromodulation
- Dec 2025Venture Round · $1M
- May 2024Accelerator/Incubator
- Dec 2021Post-IPO · $9.1M
- Dec 2021Corporate · $5M
- Dec 2021Corporate Minority
- Dec 2021Later Stage VC
- Nexalin TechnologyHouston, Texas
Neuromodulation
- May 2025PIPE · $5M
- Jun 2024PIPE · $5.3M
- UndatedDebt · $22KLed
- Aug 2011Venture Round · $502K
- SymbiosVitória, Espírito Santo, Brazil
Neurorehabilitation and assistive tech
- Oct 2025Venture Capital
- UndatedDebt · $44KLed
- Jan 2017Grant · $8.4M
- Nov 2016Grant · $4.8M
- Feb 2014Grant · $8.3M
- May 2009Conventional Debt · $2.1M
- NeuroSkySan Jose, CA
Brain-computer interfaces · EEG and neural monitoring · Wearables
- May 2020Loan · $250K
- Jan 2020Debt · $150KLed
- Apr 2015Series E
- Nov 2013Series C · $11.8M
- Nov 2013Corporate Minority
- Nov 2013Venture Round
Rounds marked Led list PPP as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Feb 2021
MedRhythms · Debt $272KLead
- Jan 2021
BIOPAC Systems · Debt $893KLead
- Jan 2021
NeuroSigma · Debt $132KLead
- Undated
Nexalin Technology · Debt $22KLead
- Undated
Symbios · Debt $44KLead
- Apr 2020
BIOPAC Systems · Debt $350KLead
- Apr 2020
MedRhythms · Debt $150KLead
- Jan 2020
NeuroSky · Debt $150KLead
Portfolio in the news
From the Cortex · last 12 months- Oct 2026
- Oct 2026
- Sep 2026
- Feb 2026